Skip to main content
Log in

Enzyme activities controlling adenosine levels in normal and neoplastic tissues

Medical Oncology Aims and scope Submit manuscript

Abstract

Adenosine is known to be associated with effects such as inhibition of immune response, coronary vasodilation, stimulation of angiogenesis, and inhibition of inflammatory reactions. Some authors suggest that adenosine may also have similar functions in tumor tissues. Tissue levels of adenosine are under close regulation by different enzymes acting at different levels. Adenosine is produced from AMP by the action of 5′-nucleotidase (5′-NT) and is converted back into AMP by adenosine kinase (AK) or into inosine by adenosine deaminase (ADA). Inosine is converted into purine catabolites by purine nucleoside phosphorylase (PNP), whereas AMP is converted into ADP and ATP by adenylate kinase (MK).

The aim of this study was to analyze the activities of the above enzymes in fragments of neoplastic and apparently normal mucosa, obtained less than 5 cm and at least 10 cm from tumors, in 40 patients with colorectal cancer.

The results showed much higher activities of ADA, AK, 5′-NT, and PNP in tumor tissue than in neighboring mucosa (p>0.01 for ADA, AK, and PNP; p>0.05 for 5′-NT), suggesting that the activities of purine metabolizing enzymes increase to cope with accelerated purine metabolism in cancerous tissue. The simultaneous increase in ADA and 5′-NT activities might be a physiological attempt by cancer cells to provide more substrate to accelerate salvage pathway activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arch JR, Newsholme E.A. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem J 1978; 174:965–977.

    PubMed  CAS  Google Scholar 

  2. Spychala J, Mitchell BS, Barankiewicz J. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation. J Immunol 1997; 158:4947–4952.

    PubMed  CAS  Google Scholar 

  3. Spychala J. Tumour-promoting function of adenosine. Pharmacol Therapy 2000; 87:161–173.

    Article  CAS  Google Scholar 

  4. Bontemps F, Vincent MF, Van den Berghe G. Mechanism of elevation of adenosine levels in anoxic hepatocytes. Biochem J 1993, 290:671–677.

    PubMed  CAS  Google Scholar 

  5. Meghji P, Middleton KM, Newby AC. Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. Biochem J 1988; 249:695–703.

    PubMed  CAS  Google Scholar 

  6. Hockel M, Vaupel P. Tumour hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 2001, 93:266–276.

    Article  PubMed  CAS  Google Scholar 

  7. Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism: a review of histochemical localization and functional implications. Histol Histopathol 1999; 14:1321–1340.

    PubMed  CAS  Google Scholar 

  8. Bianchi V, Spychala J. Mammalian 5′-nucleotidase. J Biol Chem 2003; 278:46195–46198.

    Article  PubMed  CAS  Google Scholar 

  9. Lehto MT, Sharom FJ. Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5′ nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer. Biochem J 1998; 332:101–109.

    PubMed  CAS  Google Scholar 

  10. Kowaluk EA, Bhagwat SS, Jarvis MF. Adenosine kinase inhibitors. Curr Pharmacol Des 1998; 4:403–416.

    CAS  Google Scholar 

  11. Yamada Y, Goto H, Ogasawara N. Purification and properties of adenosine kinase from rat brain. Biochim Biophys Acta 1980; 616:199–207.

    PubMed  CAS  Google Scholar 

  12. Hirschhorn R, Yang DR, Israni A. An asp8-to-asm substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA2 allozyme): occurrence in different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994; 58:1–9.

    PubMed  CAS  Google Scholar 

  13. Rubio R, Berne RM. Localization of purine and pyrimidine nucleoside phosphorylases in heart, kidney and liver. Am J Physiol 1980; 239:H721–730.

    PubMed  CAS  Google Scholar 

  14. Rao PN, et al. Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell. Hepatology 1990; 11:193–198.

    Article  PubMed  CAS  Google Scholar 

  15. Minor TH, et al. Determination of plasma activities of purine phosphorylase by high-performance liquid chromatography: estimates of non parenchyma cell injury after porcine liver transplantation. J Chromatogr B 1995; 670:332–336.

    Article  CAS  Google Scholar 

  16. Zeleznikar RJ, et al. Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle J Biol Chem 1990; 265:300–311.

    PubMed  CAS  Google Scholar 

  17. Matsuura S, et al. Human adenylate kinase deficiency associated with hemolytic anemia. J Biol Chem 1989; 264:10148–10152.

    PubMed  CAS  Google Scholar 

  18. Eroglu A, et al. Activities of adenosine deaminase and 5′-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 2000, 17:319–324.

    PubMed  CAS  Google Scholar 

  19. Majer J, Horbov S, Nygaard P. Purine metabolizing enzymes in lymphocytes from patients with solid tumours. Acta Med Scand 1984; 215:5–11.

    Article  Google Scholar 

  20. Canbolat O, et al. Activities of adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Canc Res Treat 1996; 37:189–193.

    Article  CAS  Google Scholar 

  21. Durak I, et al. Activity of the enzymes participating in purine metabolism of cancerous and non-cancerous human kidney tissues. Cancer Invest 1997; 15:212–216.

    PubMed  CAS  Google Scholar 

  22. Biri H, et al. Activities of DNA turnover and free radical metabolizing enzymes in cancerous human prostate tissue. Cancer Invest 1999; 17:314–319.

    Article  PubMed  CAS  Google Scholar 

  23. Natsumeda Y, Prajda N, Donohue JP; Glover JL, Weber G. Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Cancer Res 1984; 44:2475–2479.

    PubMed  CAS  Google Scholar 

  24. Natsumeda Y, et al. Purine enzymology of human colon carcinomas. Cancer Res 1985; 45:2556–2559.

    PubMed  CAS  Google Scholar 

  25. Wei S, et al. Purine metabolism in two human melanoma cell lines: relation to proliferation and differentiation. Melanoma Res 1999; 9:351–359.

    Article  PubMed  CAS  Google Scholar 

  26. Rendekova V, et al. Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases in bronchogenic carcinoma. Neoplasma 1983; 30:233–238.

    PubMed  CAS  Google Scholar 

  27. Harris NL, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international Lymphoma Study Group. Blood 1994; 84:1361–1392.

    PubMed  CAS  Google Scholar 

  28. Weber G. Enzymes of purine metabolism in cancer. Clin Biochem 1983; 16:57–73.

    Article  PubMed  CAS  Google Scholar 

  29. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–254.

    Article  PubMed  CAS  Google Scholar 

  30. Lin HY, Fox IH, Spychala J. ATP degradation and depletion of adenine nucleotides. In: Zelenock GB (ed). Clinical Ischemic Syndromes. Mechanism and Consequences of Tissue Injury. The C.V. Mosby Company: St. Louis, MO, 1990, pp. 159–186.

    Google Scholar 

  31. Camici M, et al. Purine salvage enzyme activities in normal and neoplastic human tissues. Cancer Biochem Biophys 1990; 11:201–209.

    PubMed  CAS  Google Scholar 

  32. Sanfilippo O, et al. Relationship between the levels of purine salvage pathway enzymes and clinical biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 1994; 14:57–66.

    PubMed  CAS  Google Scholar 

  33. Carlucci F, et al. Purine nucleotide metabolism: specific aspects in chronic lymphocytic leucemia lymphocytes. Biochim Biophys Acta 1997; 1360:203–210.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Vannoni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vannoni, D., Bernini, A., Carlucci, F. et al. Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Med Oncol 21, 187–195 (2004). https://doi.org/10.1385/MO:21:2:187

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MO:21:2:187

Key Words

Navigation